NCT00021892

Brief Summary

To assess the diagnostic and prognostic usefulness of serum markers of left ventricular remodeling for predicting congestive heart failure.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jun 2001

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2001

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 10, 2001

Completed
Same day until next milestone

First Posted

Study publicly available on registry

August 10, 2001

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2006

Completed
Last Updated

February 21, 2014

Status Verified

February 1, 2014

Enrollment Period

4.9 years

First QC Date

August 10, 2001

Last Update Submit

February 20, 2014

Conditions

Heart DiseasesHeart Failure, CongestiveCardiovascular DiseasesHeart Failure

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
No eligibility criteria

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (3)

  • Sundstrom J, Evans JC, Benjamin EJ, Levy D, Larson MG, Sawyer DB, Siwik DA, Colucci WS, Sutherland P, Wilson PW, Vasan RS. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation. 2004 Jun 15;109(23):2850-6. doi: 10.1161/01.CIR.0000129318.79570.84. Epub 2004 Jun 1.

    PMID: 15173025BACKGROUND

  • Kathiresan S, Larson MG, Benjamin EJ, Corey D, Murabito JM, Fox CS, Wilson PW, Rifai N, Meigs JB, Ricken G, Lifton RP, Levy D, Vasan RS. Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. Am J Hypertens. 2005 May;18(5 Pt 1):657-65. doi: 10.1016/j.amjhyper.2004.12.005.

    PMID: 15882548BACKGROUND

  • Dhingra R, Ho Nam B, Benjamin EJ, Wang TJ, Larson MG, D'Agostino RB Sr, Levy D, Vasan RS. Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study. J Am Coll Cardiol. 2005 Mar 1;45(5):685-9. doi: 10.1016/j.jacc.2004.11.046.

    PMID: 15734611BACKGROUND

MeSH Terms

Conditions

Heart DiseasesHeart FailureCardiovascular Diseases

Study Officials

  • Vasan Ramachandran

    Boston University

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 10, 2001

First Posted

August 10, 2001

Study Start

June 1, 2001

Primary Completion

May 1, 2006

Study Completion

May 1, 2006

Last Updated

February 21, 2014

Record last verified: 2014-02